Modeling the onset of ergodicity in digital quantum processors using statistical frameworks developed for persistent Brownian motion in biological tissues will uncover universal signatures of non-equilibrium transitions across physical and biological systems.

PhysicsApr 30, 2026Evaluation Score: 70%

Adversarial Debate Score

53% survival rate under critique

Expert panel critique

Independent views, each critiquing the hypothesis on its own — the score rewards genuine disagreement and discounts consensus.

ChatGPT: The hypothesis is falsifiable and creative, drawing an analogy between statistical models for biological tissues and quantum ergodicity, but direct support from the cited papers is limited—while they discuss ergodicity, scaling, and analogies across systems, none clearly establish that Brownian f...

Grok: The hypothesis is intriguing and falsifiable through computational and experimental testing, but it lacks direct support from the provided papers, which focus on quantum systems and hardware limitations rather than biological tissues or universal non-equilibrium signatures. Obvious counterargumen...

Mistral: The hypothesis is ambitious and conceptually intriguing, linking disparate fields (quantum ergodicity and biological Brownian motion), but its falsifiability is weakened by vague "universal signatures" and limited direct support from the cited papers, which focus narrowly on quantum systems. Coun...

Claude: The hypothesis is poorly supported because none of the relevant papers involve statistical frameworks for persistent Brownian motion in biological tissues, making the proposed cross-domain bridge entirely speculative and unsupported by the cited literature; furthermore, the claim of "universal si...

Supporting Research Papers

Onset of Ergodicity Across Scales on a Digital Quantum Processor
Understanding how isolated quantum many-body systems thermalize remains a central question in modern physics. We study the onset of ergodicity in a two-dimensional disordered Heisenberg Floquet model ...
Transition from Statistical to Hardware-Limited Scaling in Photonic Quantum State Reconstruction
The theoretical efficiency of classical shadow tomography is predicated on a perfect Haar-random unitary ensemble, yet this mathematical ideal remains physically unattainable in near-term hardware. He...
Analogue many-body gravitating quantum systems with a network of dipolar Bose-Einstein condensates
Operational probes of the interface between quantum mechanics and general relativity in the Newtonian regime -- via mass-energy equivalence in clocks or spatial superpositions in interferometers -- sh...
Ansatz-Free Learning of Lindbladian Dynamics In Situ
Characterizing the dynamics of open quantum systems at the level of microscopic interactions and error mechanisms is essential for calibrating quantum hardware, designing robust simulation protocols, ...

Formal Verification

Z3 logical consistency:✅ Consistent

Z3 checks whether the hypothesis is internally consistent, not whether it is empirically true.

Experimental Validation Package

This discovery has a Claude-generated validation package with a full experimental design.

Precise Hypothesis

Statistical estimators originally developed to characterize anomalous/persistent diffusion in biological tissue (e.g., fractional Brownian motion exponents, mean-squared-displacement scaling, ergodicity-breaking parameters such as the Lévy walk EB parameter or time-averaged MSD vs ensemble-averaged MSD divergence) can be applied to time-series of measurable observables from digital quantum processors (e.g., local magnetization decay, entanglement entropy growth, or Loschmidt echo under random circuit sampling) such that: (a) a single scalar or low-dimensional statistic computed identically in both domains distinguishes pre-thermalization (non-ergodic) from thermalized (ergodic) regimes, and (b) the functional form of the transition (e.g., critical exponent, crossover scaling) is quantitatively consistent (within stated error bars) between the biological diffusion dataset and the quantum processor dataset when time/length axes are non-dimensionalized. Falsifiable core claim: the ergodicity-breaking parameter EB(t) computed on quantum processor bitstring/observable time series will exhibit the same power-law scaling exponent (±20% or overlapping 95% CI) as EB(t) computed on established biological persistent-motion datasets, when both are rescaled by their respective correlation times.

Disproof criteria:

No statistically significant scaling collapse (R² < 0.5, or exponents differing by >50% with non-overlapping bootstrapped 95% CIs) between quantum and biological EB(t) curves after rescaling.
The apparent "ergodicity transition" on the quantum processor is fully explained by device noise/decoherence models alone (i.e., a null model without any physical thermalization reproduces the signature equally well, ΔAIC < 2).
The biological diffusion statistic is not actually sensitive to ergodicity-breaking in the tissue datasets used (i.e., fails positive control against known ergodic/non-ergodic synthetic trajectories).
Cross-domain exponents match only when hyperparameters (bin size, window length, detrending) are tuned per-domain rather than fixed a priori — indicates overfitting rather than universality.

Spine & Adversarial Read

highWhy these specific statistical estimators (TAMSD/EAMSD ergodicity-breaking parameter from biophysics) rather than established quantum-native diagnostics like out-of-time-order correlators (OTOCs), level-statistics/r-parameter, or entanglement entropy growth, which are the field-standard tools for thermalization onset in quantum many-body systems? The methodology does not justify why a biology-derived tool should outperform or add information beyond existing quantum diagnostics.
Not resolved in this EVP. A required addition before full funding: a head-to-head benchmark showing the biological EB estimator detects the ergodic transition at least as sensitively (e.g., equal or better statistical power at fixed shot budget) as OTOC or level-statistics methods on the same simulated dataset. Without this, the choice of methodology looks like relabeling existing quantum physics under a biology-flavored vocabulary rather than a genuine cross-domain discovery.
highThe claim of 'universal signatures' across physics and biology is a strong ontological claim, but the proposed test only checks for statistical curve-shape agreement (power-law exponent matching) between two unrelated systems, which is common in many unrelated stochastic processes (finite-size scaling collapses are ubiquitous and not necessarily evidence of deep universality). Two systems can share an exponent by coincidence or shared mathematical scaffolding (both are diffusive-like processes) without implying any meaningful physical unification.
Partially addressed via the null-model control and requirement for replication across 2+ independent backends/datasets, but the EVP does not include a theoretical argument for *why* the same universality class should apply (e.g., is there a proposed common renormalization-group fixed point, or is this purely phenomenological curve-fitting?). Recommend explicitly downgrading the claim in any publication to 'shared statistical signature under identical estimator' rather than 'unified physical mechanism' unless a theoretical bridge is separately established.
mediumVerification Confidence is listed at 0.00 in the discovery metadata, indicating zero independent verification of the underlying hypothesis prior to this EVP — combined with Evidence Strength of only 0.60, this suggests the discovery is speculative/generated rather than derived from preliminary empirical work, raising the risk that the entire premise (that biological ergodicity-breaking estimators are even applicable to discrete quantum circuit data) is untested at a basic feasibility level.
Addressed by Checkpoints 1-2 in ABORT_CHECKPOINTS, which require basic feasibility (estimator reproduces known biology results; quantum circuits show any differentiable regime at all) before committing to the full cross-domain comparison — but the low verification confidence justifies keeping COST_USD_MIN low (~$18K, simulator-only, no real hardware time) until Checkpoint 2 passes.

Experimental Protocol

Minimum viable test (MVT): 2-arm comparison. Arm A (biological): re-analyze 1 existing public tissue-transport single-particle-tracking (SPT) dataset with established persistent/anomalous diffusion character; compute time-averaged MSD (TAMSD), ensemble MSD (EAMSD), and ergodicity-breaking parameter EB(Δ) across lag times Δ. Arm B (quantum): run or obtain data from 1 publicly accessible digital quantum processor (e.g., IBM Quantum, 27–127 qubit device via free/open-access tier) executing a parameterized disorder Hamiltonian circuit (e.g., 1D Heisenberg chain with tunable disorder strength W) at increasing circuit depth; compute analogous EB(t) from repeated-shot local observable time series across depth. Compare: rescale both EB curves by their respective correlation/relaxation times τ; test for scaling collapse via nonlinear regression + bootstrap CI overlap; run null-model control (surrogate/shuffled data, and device noise-only simulation) for both arms.

Required datasets:

Biological: public SPT datasets with anomalous diffusion — e.g., Weron/Metzler-style intracellular transport datasets (e.g., published telomere/vesicle tracking data, or Golding & Cox E. coli mRNA tracking data), minimum 500 trajectories, ≥100 time steps each.
Quantum: IBM Quantum Experience / Qiskit Runtime job data (open plan, 127-qubit Eagle/Heron processors) or Google Quantum AI Sycamore public datasets (if available); alternatively simulated data via Qiskit Aer / QuTiP for a disordered spin chain as a controlled baseline.
Software: Python stack — qiskit, qutip, MSDanalyzer/fbm, hurst, scipy.stats, emcee or arviz for Bayesian CI estimation, numpy/pandas.
Noise model reference: IBM device calibration data (T1/T2, readout error) for the specific backend used, to build the null decoherence-only model.

Success:

Scaling collapse R² ≥ 0.85 between rescaled biological and quantum EB curves.
Fitted exponents agree within 20% relative difference AND 95% CIs overlap.
Noise-only null model rejected at ΔAIC > 10 (genuine dynamical signal, not artifact).
Replicates on ≥2 independent quantum backends and ≥2 independent biological datasets (both directions of generalization).
Positive controls (known synthetic ergodic vs non-ergodic trajectories) correctly classified with ≥90% accuracy by the same pipeline.

Failure:

R² < 0.5 for scaling collapse, or exponent disagreement >50% with non-overlapping CIs.
Noise-only null model statistically indistinguishable from real data (ΔAIC < 2).
Pipeline fails positive/negative synthetic controls (misclassifies known ergodic/non-ergodic reference trajectories).
Result only reproduces on 1 of 2+ backends/datasets (non-generalizable, likely device-specific artifact).

150

GPU hours

75d

Time to result

$18,000

Min cost

$95,000

Full cost

ROI Projection

Implementation Sketch

# Phase 1: Biological positive control
load_SPT_dataset(source="Golding_Cox_mRNA" or "public_vesicle_tracking")
traj = preprocess(trajectories, min_length=100)
TAMSD, EAMSD = compute_msd(traj)
EB_bio = ergodicity_breaking_parameter(TAMSD, EAMSD, lag=Delta)
validate_against_published_alpha(EB_bio, tolerance=0.10)

# Phase 2: Quantum data acquisition
backend = qiskit.providers.ibmq.get_backend("ibm_XXX_127q")
for W in disorder_strengths:               # W = 0 (ergodic) ... W_max (MBL-like)
    for d in depths:                        # circuit depth proxy for time
        circuit = build_disordered_heisenberg(n_qubits=20, W=W, depth=d)
        counts = execute(circuit, backend, shots=4096)
        imbalance[d][W] = compute_imbalance(counts)

EB_quantum = ergodicity_breaking_parameter(imbalance, axis="depth")

# Phase 3: Null model
noise_model = build_noise_model(backend.calibration_data)
sim_null = execute(circuit, AerSimulator(noise_model), shots=4096)
EB_null = ergodicity_breaking_parameter(sim_null)

# Phase 4: Cross-domain comparison
rescale(EB_bio, tau_bio=fit_correlation_time(EB_bio))
rescale(EB_quantum, tau_q=fit_correlation_time(EB_quantum))
collapse_fit = nonlinear_regression(EB_bio_rescaled, EB_quantum_rescaled)
report(R2=collapse_fit.R2, exponents=collapse_fit.params,
       null_comparison=AIC(EB_quantum) - AIC(EB_null))

Abort checkpoints:

Checkpoint 1 (Day 10): Biological pipeline fails to reproduce published α exponents within 10% on positive-control dataset → abort/redesign estimator before touching quantum data.
Checkpoint 2 (Day 25): Quantum circuits fail to show any W-dependent imbalance decay differentiation (ergodic vs MBL regimes indistinguishable even in ideal simulation) → abort, redesign circuit/Hamiltonian choice.
Checkpoint 3 (Day 45): Noise-only null model already reproduces observed EB(d) curve on real hardware (ΔAIC < 2) → abort claim of genuine physical signature, pivot to noise-characterization paper instead.
Checkpoint 4 (Day 60): Scaling collapse R² < 0.5 after all pre-registered rescaling → abort full unification claim; report negative result.

NAMED_EXPERTS: []

CLOSEST_EXISTING_WORK: []

NOVELTY_NARROWING_REQUIRED: false

SPINE_STATEMENT: This hypothesis tests whether a single ergodicity-breaking statistical estimator, applied without modification to both biological single-particle-tracking data and digital quantum processor observable time series, produces quantitatively matching scaling exponents after time-rescaling.

Source

AegisMind Research

Need AI to work rigorously on your problems? AegisMind uses the same multi-model engine for personal and professional use. Get started